November 19, 2001 Inpharzam, S.A. Via Industria 1 6814 Cadempino Switzerland Attention: Managing Director RE: COLLABORATION AGREEMENT, DATED MAY 21, 1999, BETWEEN CORIXA CORPORATION AND INPHARZAM INTERNATIONAL, S.A., A WHOLLY OWNED SUBSIDIARY OF...Collaboration Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances)
RECITALSResearch Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
RECITALSCollaboration and License Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
AGREEMENTResearch and Development • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Massachusetts
RECITALSLicense Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
ANDLicense and Collaborative Research Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • New York
WITNESSETHLease Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances)
WITNESSETH:Multi-Field Vaccine Discovery Collaboration and License Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
Exhibit 10.86 *Certain confidential information contained in this document, marked by brackets, has been omitted and filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended...Commercialization Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Michigan
Exhibit 10.87 ASSIGNMENT OF COMMERCIALIZATION AGREEMENT This is an Agreement, effective as of the 1st day of April, 1995 (the EFFECTIVE DATE), among Coulter Pharmaceutical, Inc., a corporation incorporated in the State of Delaware, with offices...Assignment of Commercialization Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances)
Exhibit 10.88 *Certain confidential information contained in this document, marked by brackets, has been omitted and filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended AMENDMENT...Commercialization Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances)
BACKGROUNDAgreement Regarding Sublicenses • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Massachusetts
